Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Different Clinical Layouts of Chinese-produced Products for Marching into the Anti-PD-1 Monoclonal Antibody Market

PharmaSources/XiaoyaowanJuly 04, 2019

Tag: monoclonal antibody , Anti-PD-1 , NMPA , camrelizumab

PharmaSources Customer Service